Redmile Group as of June 30, 2015
Portfolio Holdings for Redmile Group
Redmile Group holds 55 positions in its portfolio as reported in the June 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Array BioPharma | 8.1 | $98M | 14M | 7.21 | |
| Amicus Therapeutics (FOLD) | 7.3 | $89M | 6.3M | 14.15 | |
| Valeant Pharmaceuticals Int | 7.0 | $85M | 385k | 222.15 | |
| Clovis Oncology | 5.5 | $67M | 760k | 87.88 | |
| Teva Pharmaceutical Inds Adr (TEVA) | 4.7 | $57M | 967k | 59.10 | |
| Allergan SHS | 3.4 | $42M | 137k | 303.46 | |
| Kythera Biopharmaceuticals I | 3.0 | $36M | 483k | 75.31 | |
| Hca Holdings (HCA) | 2.9 | $35M | 390k | 90.72 | |
| Abbvie (ABBV) | 2.8 | $34M | 510k | 67.19 | |
| Aetna | 2.8 | $34M | 264k | 127.46 | |
| Chimerix (CMRX) | 2.6 | $32M | 699k | 46.20 | |
| CIGNA Corporation | 2.6 | $32M | 199k | 162.00 | |
| Biogen Idec (BIIB) | 2.6 | $32M | 79k | 403.94 | |
| BioMarin Pharmaceutical (BMRN) | 2.3 | $28M | 208k | 136.78 | |
| Receptos | 2.2 | $27M | 144k | 190.05 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.2 | $27M | 151k | 176.07 | |
| Seattle Genetics | 2.1 | $26M | 529k | 48.40 | |
| Universal Hlth Svcs CL B (UHS) | 2.0 | $25M | 176k | 142.10 | |
| Health Net | 2.0 | $25M | 388k | 64.12 | |
| Alere | 2.0 | $24M | 461k | 52.75 | |
| Nanostring Technologies (NSTGQ) | 1.8 | $23M | 1.5M | 15.42 | |
| Sage Therapeutics (SAGE) | 1.7 | $21M | 290k | 73.00 | |
| Insmed Com Par $.01 (INSM) | 1.7 | $21M | 867k | 24.42 | |
| Atara Biotherapeutics | 1.6 | $20M | 373k | 52.76 | |
| Intra Cellular Therapies (ITCI) | 1.6 | $20M | 610k | 31.95 | |
| Gw Pharmaceuticals Ads | 1.5 | $18M | 146k | 122.84 | |
| Incyte Corporation (INCY) | 1.4 | $17M | 165k | 104.21 | |
| Model N (MODN) | 1.4 | $17M | 1.4M | 11.91 | |
| Oxford Immunotec Global Ord Shs | 1.4 | $17M | 1.2M | 13.85 | |
| Castlight Health CL B | 1.3 | $16M | 2.0M | 8.14 | |
| Zs Pharma | 1.3 | $16M | 303k | 52.39 | |
| Oncothyreon | 1.3 | $16M | 4.2M | 3.74 | |
| Civitas Solutions | 1.1 | $14M | 658k | 21.33 | |
| Fate Therapeutics (FATE) | 1.1 | $13M | 2.0M | 6.47 | |
| DaVita (DVA) | 0.9 | $11M | 140k | 79.47 | |
| Blueprint Medicines (BPMC) | 0.8 | $9.7M | 378k | 25.57 | |
| Avalanche Biotechnologies In | 0.7 | $8.7M | 537k | 16.24 | |
| Proqr Thrapeutics N V Shs Euro (PRQR) | 0.7 | $8.6M | 517k | 16.67 | |
| Genocea Biosciences | 0.7 | $8.6M | 624k | 13.73 | |
| D Fluidigm Corp Del (LAB) | 0.7 | $8.4M | 348k | 24.20 | |
| Cerus Corporation (CERS) | 0.7 | $8.3M | 1.6M | 5.19 | |
| Trivascular Technologies | 0.6 | $7.8M | 1.5M | 5.35 | |
| Portola Pharmaceuticals | 0.6 | $7.0M | 153k | 45.55 | |
| Ultragenyx Pharmaceutical (RARE) | 0.6 | $6.9M | 67k | 102.40 | |
| Bellicum Pharma | 0.4 | $5.1M | 238k | 21.27 | |
| Array Biopharma Note 3.000% 6/0 (Principal) | 0.4 | $5.1M | 4.0M | 1.26 | |
| Chemocentryx | 0.3 | $3.9M | 476k | 8.23 | |
| Eleven Biotherapeutics | 0.3 | $3.6M | 1.3M | 2.82 | |
| Flexion Therapeutics | 0.3 | $3.1M | 143k | 21.89 | |
| Axovant Sciences | 0.3 | $3.1M | 150k | 20.38 | |
| Invitae (NVTAQ) | 0.2 | $2.6M | 181k | 14.14 | |
| Aduro Biotech | 0.2 | $1.9M | 62k | 30.34 | |
| Ishares Us Hlthcr Pr Etf (IHF) | 0.1 | $1.2M | 8.6k | 142.92 | |
| Celldex Therapeutics | 0.1 | $826k | 33k | 25.21 | |
| Market Vectors Etf Tr Pharmaceutical | 0.0 | $460k | 6.5k | 70.77 |
